FDA - Search News

FDA Approves 1st Non-Opioid Pain Medicine in 20 Years

U.S. News & World Report · 35m

What to Know: FDA Approves Non-Opioid Pain Medication, Journavx

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

Live Science · 1h

FDA approves 1st new class of opioid-free painkillers in over 20 years

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

CNN on MSN · 16h

FDA approves first new type of pain medication in 25 years

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.

FDA, recall and Chocolate

YAHOO!News · 3h

Chocolate recall elevated by FDA on products sold in Tennessee. Here's what to know

Nine states have been identified as being affected by the chocolate recall, but the products were available online so others could have the products as well. Consumers affected bought products from the retail store located at 5158 Clayton Road, Suisun Valley, CA 94534, and online through calyeefarm.com.

This chocolate recall has been upgraded to FDA’s highest risk level

A December 2024 chocolate recall has been upgraded to highest risk level by the U.S. Food and Drug Administration (FDA), which says consuming the product could “cause serious adverse health consequences or death.

Chocolate Recall Updated to Highest Risk Level, FDA Warns Consumption Could Cause Death

Cal Yee Farms' dark chocolate walnuts, dark chocolate almonds and dark chocolate apricots have been given a Class 1 recall classification because the chocolates contained undeclared milk

Hosted on MSN25m

FDA approves 'ketamine' nasal spray for depression — here's everything you need to know

A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

2don MSN

FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

11m

Amazon agrees to pay $6M and block sales of skin-lightening creams containing mercury, settling a decadelong lawsuit

Amazon has agreed to block sales of skin-lightening creams containing dangerous amounts of mercury.

clickondetroit.com50m

Child killed in hyperbaric chamber explosion at Oakland County healthcare facility

A 5-year-old boy from Royal Oak was killed in an explosion while receiving hyperbaric oxygen therapy at a healthcare facility ...

FDA Bans Red Dye No. 3 in Food and Ingested Drugs: What Manufacturers Should Know

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

CISA, FDA warn of vulnerabilities in Contec patient monitors

The Cybersecurity and Infrastructure Security Agency and Food and Drug Administration Jan. 30 released notices warning of ...

Ever-Growing USA on MSN29m

Blue Salt Trick: The Male Enhancement Formula Redefining Vitality and Confidence

In today's world, many men are seeking effective solutions to enhance their performance and regain confidence. Whether it's ...

Hosted on MSN1d

Frito-Lay Recalls 6,000 Bags of Lay’s Potato Chips Due to Dairy Allergen Risk

Frito-Lay has recalled over 6,000 bags of Lay’s Classic Potato Chips due to undeclared milk, which poses a serious risk to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results